Update on regional treatments for hepatobiliary malignancies.
Curley
S A
SA
Dept. of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, USA.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000628:therapy*; D006528:Carcinoma, Hepatocellular / Q000556:secondary / Q000628:therapy*; D015179:Colorectal Neoplasms / Q000473:pathology; D003452:Cryosurgery; D017679:Cryotherapy; D004317:Doxorubicin / Q000008:administration & dosage; D000431:Ethanol / Q000008:administration & dosage; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006499:Hepatic Artery; D006801:Humans; D007261:Infusions, Intra-Arterial; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000556:secondary / Q000628:therapy*; D008297:Male; D016896:Treatment Outcome
D005467:Floxuridine; D000431:Ethanol; D004317:Doxorubicin; D005472:Fluorouracil